Success Metrics

Clinical Success Rate
88.8%

Based on 182 completed trials

Completion Rate
89%(182/205)
Active Trials
93(23%)
Results Posted
10%(19 trials)
Terminated
23(6%)

Phase Distribution

Ph early_phase_1
2
0%
Ph phase_1
2
0%
Ph phase_2
27
7%
Ph not_applicable
39
10%
Ph phase_4
2
0%
Ph phase_3
31
8%

Phase Distribution

4

Early Stage

27

Mid Stage

33

Late Stage

Phase Distribution103 total trials
Early Phase 1First-in-human
2(1.9%)
Phase 1Safety & dosage
2(1.9%)
Phase 2Efficacy & side effects
27(26.2%)
Phase 3Large-scale testing
31(30.1%)
Phase 4Post-market surveillance
2(1.9%)
N/ANon-phased studies
39(37.9%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

87.1%

182 of 209 finished

Non-Completion Rate

12.9%

27 ended early

Currently Active

93

trials recruiting

Total Trials

402

all time

Status Distribution
Active(121)
Completed(182)
Terminated(27)
Other(72)

Detailed Status

Completed182
Recruiting74
unknown70
Not yet recruiting24
Terminated23
Active, not recruiting19

Development Timeline

Analytics

Development Status

Total Trials
402
Active
93
Success Rate
88.8%
Most Advanced
Phase 4

Trials by Phase

Early Phase 12 (1.9%)
Phase 12 (1.9%)
Phase 227 (26.2%)
Phase 331 (30.1%)
Phase 42 (1.9%)
N/A39 (37.9%)

Trials by Status

withdrawn41%
active_not_recruiting195%
completed18245%
terminated236%
not_yet_recruiting246%
recruiting7418%
enrolling_by_invitation41%
suspended20%
unknown7017%

Recent Activity

Clinical Trials (402)

Showing 20 of 402 trialsScroll for more
NCT07645976

Home Environmental Risks and Caregiver Awareness

Completed
NCT05257551

TEMPUS Small Cell Lung Cancer OBSERVATIONAL STUDY (Sculptor)

Recruiting
NCT04388943

Biomedical Research Informatics Centre for Cardiovascular Sciences (The BRICCS Study)

Recruiting
NCT07513324Phase 2

Risk-adapted Therapy in HPV-positive Oropharyngeal Cancer Using Circulating Tumor (ct) HPV DNA Profiling (ReACT 2.0)

Not Yet Recruiting
NCT05640999Phase 2

Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER

Recruiting
NCT07610356

Predictors of Transmural Non-Occlusive Mesenteric Ischemia in ICU Patients With Suspected Acute Mesenteric Ischemia

Recruiting
NCT03414151

Gut Microbiome in AP Naive

Active Not Recruiting
NCT05976347Phase 4

Identifying and Treating Depression in the Orthopaedic Trauma Population

Recruiting
NCT05119387

Genetic Study of Amyotrophic Lateral Sclerosis in Norway

Recruiting
NCT07596524

Analysis of Different Second Line Treatment in Advanced NSCLC Patients Progressing After 1st Line Immune Checkpoint Inhibitor Therapy

Not Yet Recruiting
NCT05255653Phase 2

Refining Adjuvant Treatment IN Endometrial Cancer Based On Molecular Features

Recruiting
NCT07563088

SPARE-1st: Surgery Alone vs Surgery Plus Postoperative Radiotherapy for Sinonasal Adenoid Cystic Carcinoma

Not Yet Recruiting
NCT05601440Phase 2

Liquid-biopsy Informed Platform Trial to Evaluate CDK4/6-inhibitor Resistant ER+/HER2- Metastatic Breast Cancer

Recruiting
NCT06187974

Relationship of Proprioception, Reaction Time and the Gait and Balance Parameters After Stroke

Completed
NCT07128966

Direct to Patient Minimal Risk Biospecimen and Data Collection Research

Recruiting
NCT07410247

MPN Childhood Registry

Recruiting
NCT07215325Phase 4

Got Doxy- 'Flipping the Script' on STI PEP

Recruiting
NCT04939896

Study on the Trajectories of Rehabilitation Compliance in Stroke Patients

Completed
NCT06692257

Orofacial Functions in Individuals With and Without Molar Incisor Hypomineralization

Completed
NCT07542301

Breathing Patterns in Infants Before and After Extubation

Recruiting

Drug Details

Intervention Type
OTHER
Total Trials
402